IIT Bombay study gives hope to resistant-TB patients - IIT Club
IIT Bombay study gives hope to resistant-TB patientsMumbai | India
In what can bring hope for drug-resistant TB patients, a study conducted by IIT-Bombay has shown that an anti-TB drug - rifampicin - used in combination with other drugs, can significantly improve medicinal efficacy. Rifampicin is one of the two main powerful drugs that TB bacteria are resistant to in multiple-drug resistant TB, or MDR TB cases.
Times of India | Last Updated : 14-Feb-19Know more